These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 20712869

  • 1. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 2. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan 16; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 3. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.
    Clin Interv Aging; 2014 Jan 16; 9():947-61. PubMed ID: 24971004
    [Abstract] [Full Text] [Related]

  • 4. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P.
    J Child Adolesc Psychopharmacol; 2018 Dec 16; 28(10):699-710. PubMed ID: 30132686
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct 16; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 6. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep 16; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.
    Lemoine P, Wade AG, Katz A, Nir T, Zisapel N.
    Integr Blood Press Control; 2012 Sep 16; 5():9-17. PubMed ID: 22346363
    [Abstract] [Full Text] [Related]

  • 8. Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
    Roth T, Nir T, Zisapel N.
    Nat Sci Sleep; 2015 Sep 16; 7():13-23. PubMed ID: 25678831
    [Abstract] [Full Text] [Related]

  • 9. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
    Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N.
    Ther Clin Risk Manag; 2011 Sep 16; 7():301-11. PubMed ID: 21845053
    [Abstract] [Full Text] [Related]

  • 10. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec 16; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM, Broquère MA, Claustrat B, Delorme R, Franco P, Lecendreux M, Tordjman S.
    Encephale; 2022 Jun 16; 48(3):294-303. PubMed ID: 35120753
    [Abstract] [Full Text] [Related]

  • 12. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z.
    Arch Womens Ment Health; 2011 Jun 16; 14(3):269-73. PubMed ID: 21311927
    [Abstract] [Full Text] [Related]

  • 13. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 16; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.
    Sleep; 2010 Nov 16; 33(11):1553-61. PubMed ID: 21102997
    [Abstract] [Full Text] [Related]

  • 15. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D, Laudon M, Nof D, Zisapel N.
    Lancet; 1995 Aug 26; 346(8974):541-4. PubMed ID: 7658780
    [Abstract] [Full Text] [Related]

  • 16. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
    Hajak G, Lemme K, Zisapel N.
    Int Clin Psychopharmacol; 2015 Jan 26; 30(1):36-42. PubMed ID: 25054634
    [Abstract] [Full Text] [Related]

  • 17. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH, Kim M, Park S, Jang W, Park J, Oh E, Cho JW, Kim JS, Youn J.
    Parkinsonism Relat Disord; 2020 Jun 26; 75():50-54. PubMed ID: 32480307
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 26; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 19. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA.
    Drugs Aging; 2012 Nov 26; 29(11):911-23. PubMed ID: 23044640
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL.
    J Am Acad Child Adolesc Psychiatry; 2017 Nov 26; 56(11):948-957.e4. PubMed ID: 29096777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.